New Website coming
Levron Medical Awarded First Place at ICI Cardiology Conference
LOG IN
Levron Medical introduces a novel and fresh approach to the treatment of Heart Failure, with elegance and simplicity like no other.
The company is based on the lifelong research of Prof. Amir Landesberg, from the Biomedical Engineering department in the Technion.
About (still in stealth mode)
Levron is a pioneer of a new category of Heart Failure treatment:
Cardio-Respiratory Physiological Assist (CRPA) Treatment.
Introducing a New Category
Our Team
Amir Ronen is an entrepreneur and a seasoned executive in the Israeli hi-tech scene. A co-founder and CEO for 15 years in the Heart Failure medical device space, and previously a VP in NASDAQ traded companies all which have been merged and acquired (Sensible Medical $150M; M-Systems $1.4B; Saifun $384M). Amir holds a BsC in Electronic Engineering from the Technion and an MBA from Kellogg IMBA.
Professor and former dean of the biomedical engineering faculty at the Technion and former president of the International Society for Heart Research Israel group. Prof. Landesberg holds a Phd. In biomedical engineering and an M.D. Cum-Laude both from the Technion
Dr. Eckhouse is the founder and chairman of Alon MedTech ventures, a major player in the Israeli medical eco system, founded and invested in 20+ companies. such as Syneron Medical (acquired for $400M) and Ventor technologies (acquired for $325M)
Dr. Livneh is an R&D executive with extensive experience in preclinical and clinical cardiovascular research and development, specializing in real-time biomedical signal processing, machine learning and data science. Dr. Livneh holds a PhD. in Biomedical Engineering from the Technion, an MSc. in Electrical Engineering from Tel-Aviv University, and a BSc. in Electrical Engineering from the Technion.
GET IN TOUCH
Tavor 2 Building, 3rd Floor, Hakidma 28, Yokneam, Israel
+972-54-3113699